Work

GWAS of Longevity in CHARGE Consortium Confirms APOE and FOXO3 Candidacy

Year: 2014
Type: article
Abstract: BACKGROUND: The genetic contribution to longevity in humans has been estimated to range from 15% to 25%. Only two genes, APOE and FOXO3, have shown association with longevity in multiple independent studies. METHODS: We conducted a meta-analysis of genome-wide association studies including 6,036 longevity cases, age ≥90 years, and 3,757 controls that died between ages 55 and 80 years. We additionally attempted to replicate earlier identified single nucleotide polymorphism (SNP) associations with longevity. RESULTS: In our meta-analysis, we found suggestive evidence for the association of SNPs near CADM2 (odds ratio [OR] = 0.81; p value = 9.66 × 10(-7)) and GRIK2 (odds ratio = 1.24; p value = 5.09 × 10(-8)) with longevity. When attempting to replicate findings earlier identified in genome-wide association studies, only the APOE locus consistently replicated. In an additional look-up of the candidate gene FOXO3, we found that an earlier identified variant shows a highly significant association with longevity when including published data with our meta-analysis (odds ratio = 1.17; p value = 1.85×10(-10)). CONCLUSIONS: We did not identify new genome-wide significant associations with longevity and did not replicate earlier findings except for APOE and FOXO3. Our inability to find new associations with survival to ages ≥90 years because longevity represents multiple complex traits with heterogeneous genetic underpinnings, or alternatively, that longevity may be regulated by rare variants that are not captured by standard genome-wide genotyping and imputation of common variants.
Language: English
Subfield: Genetics
Open Access status: bronze
Awards: G1023702118, G1028935811, G1068966504, G1089665818, G1097528416, G1224608327, G1233934336, G1248102086, G125972088, CORONARY HEART DISEASE AND STROKE, G1282666458, G1287431292, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G130287077, G1343274610, G1344639305, UC Davis Alzheimer's Disease Core Center, G1352229255, G1379949353, G1401438683, G1438302022, G1450322595, G1462415530, G1495020029, THE AGES STUDY - THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENUM, CORONARY HEART DISEASE AND STROKE, G1613471689, G1711508895, G1726490033, G177655820, G1789381357, G1852751850, G187300890, G1922810624, Osteoporotic Fractures in Men, G199972683, G201653045, G2060701114, G2077504343, G2091924775, G2193588257, G2200385677, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G2260233006, G2279902555, G230712557, G232440474, G2404662676, G2450915342, G245238184, G247538147, G2495888254, G249615658, G250621538, G2555954497, G2576967755, G262043649, CORONARY HEART DISEASE &STROKE IN THE ELDERLY, G2644159154, G2681271563, G270907595, G271331228, G2736147164, Bone Strength Phenotypes in men: Genes and Environment, G2786044735, G2800149121, Exceptional Aging Across the Life Span: Framingham Study, G2857511458, G2918387404, G297113894, WGA Study to Identify Genetic Variants Associated with CV Events in CHS, G3049017749, G3137375862, G3167614921, G3205625555, G321186775, G3220743633, G322252321, UCLA Clinical and Translational Science Institute, G3327847537, G3362311673, G337426736, G3402222819, G3428355823, G34347772, G3478357739, G36433118, G3664726445, G3692229207, G36937976, GWAS in MrOS and SOF, G3723061141, G3743240706, G374919288, G3835417588, G3839646794, G3922592609, Osteoporotic Fractures in Men - MrOS Renewal, G3990106893, CENTRAL BLOOD ANALYSIS LABORATORY FOR CHS, Osteoporotic Fractures in Men, G4057369848, G4118007464, G4122201895, G4219624527, G423252844, Study of Osteoporotic Fractures, G430788307, G4380859766, G4426619567, G4429312988, G4498387036, G4507648799, Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham Study, G4592101486, G4622379297, G4652745033, G4660668308, Study of Osteoporotic Fractures, G4710253500, G4942589162, G5018925220, G5046588511, G5145575165, G5206110354, G5251985303, G5281659474, G5292240182, G541333419, G544148272, G5457026379, G5479317095, G5665886026, G5685595568, G5688239834, G5713958695, G5716343413, G573134505, G5855802124, G585648573, G5909276777, G616491540, G6311601004, The Framingham Heart Study, G6589694607, G659495149, G682487154, G683030897, G6832344490, Study of Osteoporotic Fractures, G6868950288, G6879233014, G6958519851, G7004081433, G7007046788, G7058527481, G7078612884, G7200248429, G7217924807, G7270237958, G7333524540, G7373387228, G7479973302, G7505613430, G7589654153, G76550502, G766700449, G777822606, G778393479, ReliabilitY of opto-Transceivers for Health Monitoring Systems, G789494128, G801436702, G80149192, G806768229, G8151528796, G828200374, G8492638969, Risk Factors, Pathology, and Clinical Expressions of AD, G8506930532, G8541424066, G854822065, G859169766, CHS-Transition Phase -268055222, HISPANIC SECONDARY STROKE PREVENTION INITIATIVE, G8748734468, G8781403166, G890705022, G9000015626, G9000018859, G9000021615, G9000033828, G9000046001, G9000057500, G9000058914, G9000064213, G9000069887, G9000084591, G9000085452, G9000086042, G9000088118, G9000095940, G9000099765, G9000111449, G9000111864, G9000121640, G9000124008, G9000124674, G9000139054, G9000140433, G9000155215, G9000165958, G9000167181, G9000179763, G9000193621, G9000208878, G9000243027, G9000244657, G9000264251, G9000275219, G9000291326, G9000294005, G9000323844, G9000335375, G9000354222, G9000354881, Diabetes Research Center (DRC), G905887895, G955951203, G972017601, G983864884
OpenAlex ID: W2171241286
FWCI: 14.85
Cites: 50
Cited by: 277
Related to: 10